Medicine and Dentistry
Insulin Receptor Substrate 2
92%
Interleukin 4
64%
Glucose
50%
Phosphoinositide 3-Kinase
50%
Phosphorylation
42%
Macrophage
42%
Mechanistic Target of Rapamycin
21%
Maturity Onset Diabetes of the Young
14%
Heterozygote
14%
Serine
14%
U937 Cell
14%
Hyperinsulinemia
7%
Interferon
7%
Protein Phosphorylation
7%
Rapamycin
7%
JAK-STAT Signaling
7%
Cells
7%
Association
7%
Resident
7%
Insulin Receptor Substrate
7%
Neuroscience
Insulin Receptor
100%
Interleukin 4
64%
Phosphoinositide 3-Kinase
50%
Insulin
50%
Glucose
50%
Phosphorylation
42%
Mammalian Target of Rapamycin
21%
Diabetes Mellitus
14%
Serine
14%
Protein Phosphorylation
7%
Acetate
7%
Interferon
7%
Hyperinsulinemia
7%
JAK-STAT Signaling Pathway
7%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Receptor Substrate 2
92%
Interleukin 4
64%
Insulin
50%
Phosphatidylinositol 3 Kinase
50%
Glucose
50%
Mammalian Target of Rapamycin
21%
Db/Db Mouse
14%
Non Insulin Dependent Diabetes Mellitus
14%
Serine
14%
Interferon
7%
Hyperinsulinemia
7%
12-O-Tetradecanoylphorbol-13-Acetate
7%
Mouse
7%
Insulin Receptor Substrate
7%
Biochemistry, Genetics and Molecular Biology
Insulin Receptor
100%
Interleukin 4
64%
Insulin
50%
Glucose
50%
Phosphorylation
42%
Serine
14%
Db/Db Mouse
14%
Tyrosine Phosphorylation
7%
Interferon
7%
Mouse
7%
Genetic Carrier
7%
Reduction (Chemistry)
7%
Association
7%
JAK-STAT Signaling Pathway
7%
Immunology and Microbiology
Insulin Receptor
100%
Interleukin 4
64%
Phosphorylation
42%
Cells
21%
Db/Db Mouse
14%
Interferon Type I
7%
Protein Phosphorylation
7%
Sirolimus
7%
Mouse
7%
JAK-STAT Signaling
7%
Association
7%
Reduction (Chemistry)
7%